IP Library › Patent Application 18120231
Patent Application
App. No. 18/120,231

MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/120,231
Abstract

Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.

Claims (1)

1 . A method of treating cataplexy or excessive daytime sleepiness in a human subject with narcolepsy as disclosed herein.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded May 21, 2026
From: RTW INVESTMENTS, LP, AS COLLATERAL AGENT
To: AVADEL CNS PHARMACEUTICALS, LLC; FLAMEL IRELAND LTD.
Reel/Frame 074729/0205 →
PATENT COLLATERAL AGREEMENT Recorded Aug 1, 2023
From: AVADEL CNS PHARMACEUTICALS, LLC; FLAMEL IRELAND LTD.
To: RTW INVESTMENTS, LP
Reel/Frame 064463/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2023
From: DUBOW, JORDAN; GUILLARD, HERVÉ; MÉGRET, CLAIRE; DUBUISSON, JEAN-FRANÇOIS
To: FLAMEL IRELAND LIMITED
Reel/Frame 063593/0573 →